Table 3.

Patients with invasive treatment

	Included patients with HCA n = 18
Age at treatment, y	32 (32.0‐39.5)
HCA and OCP characteristics
HCA diameter at baseline, mm	93.5 (71.5‐120.8)
HCA diameter before intervention, mm	80.5 (61.0‐102.3)
Interval between cessation of OCP and intervention, months	11.0 (4.8‐14.3)
Treatment type
Resection	15 (83.3%)
Percutaneous thermal ablation	2 (11.1%)
Transarterial embolization	1 (5.6%)
Indication
HCA size ≥50mm after lifestyle advices	9 (50.0%)
Unable to rule out malignancy	4 (22.2%)
Patient’s own wish	3 (16.7%)
HCA‐induced symptoms	1 (5.6%)
Wish to become pregnant	1 (5.6%)

HCA, hepatocellular adenoma; OCP, oral contraceptive pill. Values are given in median (interquartile range) or n (%).